Skip to main content

A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia

Pilocarpine After Combined Cataract/Trabectome Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Pilocarpine After Combined Cataract/Trabectome Surgery

Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Open-Label Safety and Tolerability Study of NBI-98854 for the Treatment of Pediatric Subjects With Tourette Syndrome

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial Fibrillation

Afatinib Osimertinib Sequencing NIS

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Afatinib Osimertinib Sequencing NIS

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • …
  • Next page Next
  • Last page Last
Subscribe to